Historical award
Dakota Drug, Inc.
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (13 days old).
Fiscal year 2026: data through (13 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $423.78
- Potential award value
- $423.78
- Total obligated to date
- $423.78
Source date: Oct 14, 2026
Recorded work
4567104983!NEOMYCIN-POLYMYXIN-HC EAR SUSP 10ML
Award activity
- Obligations in covered fiscal years
- $423.78
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_SPE2DB25FJTTD_9700_SPE2DB24D8003_9700